Cargando…
Defibrotide in the treatment of hepatic veno-occlusive disease
Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), represents the most frequent complication in patients in early phase following hematopoietic stem-cell transplantation (HSCT). In its severe form, VOD/SOS can be associated with multiorgan failure and with a m...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098529/ https://www.ncbi.nlm.nih.gov/pubmed/27843363 http://dx.doi.org/10.2147/HMER.S79243 |
_version_ | 1782465797712510976 |
---|---|
author | Fulgenzi, Alessandro Ferrero, Maria Elena |
author_facet | Fulgenzi, Alessandro Ferrero, Maria Elena |
author_sort | Fulgenzi, Alessandro |
collection | PubMed |
description | Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), represents the most frequent complication in patients in early phase following hematopoietic stem-cell transplantation (HSCT). In its severe form, VOD/SOS can be associated with multiorgan failure and with a mortality rate >80% by day +100. Defibrotide (DF) (a mixture of 90% single-stranded phosphodiester oligonucleotides and 10% double-stranded phosphodiester oligonucleotides derived from controlled depolarization of porcine intestinal mucosal DNA) has been proposed for the treatment of SOS due to its ability to restore thrombo-fibrinolytic balance and protect endothelial cells. The present review highlights why the mechanisms of action of DF allow its successful use in the prevention and treatment of SOS following HSCT. |
format | Online Article Text |
id | pubmed-5098529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-50985292016-11-14 Defibrotide in the treatment of hepatic veno-occlusive disease Fulgenzi, Alessandro Ferrero, Maria Elena Hepat Med Review Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), represents the most frequent complication in patients in early phase following hematopoietic stem-cell transplantation (HSCT). In its severe form, VOD/SOS can be associated with multiorgan failure and with a mortality rate >80% by day +100. Defibrotide (DF) (a mixture of 90% single-stranded phosphodiester oligonucleotides and 10% double-stranded phosphodiester oligonucleotides derived from controlled depolarization of porcine intestinal mucosal DNA) has been proposed for the treatment of SOS due to its ability to restore thrombo-fibrinolytic balance and protect endothelial cells. The present review highlights why the mechanisms of action of DF allow its successful use in the prevention and treatment of SOS following HSCT. Dove Medical Press 2016-10-31 /pmc/articles/PMC5098529/ /pubmed/27843363 http://dx.doi.org/10.2147/HMER.S79243 Text en © 2016 Fulgenzi and Ferrero. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Fulgenzi, Alessandro Ferrero, Maria Elena Defibrotide in the treatment of hepatic veno-occlusive disease |
title | Defibrotide in the treatment of hepatic veno-occlusive disease |
title_full | Defibrotide in the treatment of hepatic veno-occlusive disease |
title_fullStr | Defibrotide in the treatment of hepatic veno-occlusive disease |
title_full_unstemmed | Defibrotide in the treatment of hepatic veno-occlusive disease |
title_short | Defibrotide in the treatment of hepatic veno-occlusive disease |
title_sort | defibrotide in the treatment of hepatic veno-occlusive disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098529/ https://www.ncbi.nlm.nih.gov/pubmed/27843363 http://dx.doi.org/10.2147/HMER.S79243 |
work_keys_str_mv | AT fulgenzialessandro defibrotideinthetreatmentofhepaticvenoocclusivedisease AT ferreromariaelena defibrotideinthetreatmentofhepaticvenoocclusivedisease |